Document is current
Any future updates will be listed below
-
Authors
Davies, Anna http://orcid.org/0000-0003-0743-6547
Lenguerrand, Erik http://orcid.org/0000-0002-0371-731X
Scott, Eleanor http://orcid.org/0000-0001-5395-8261
Kandiyali, Rebecca http://orcid.org/0000-0001-8566-9536
Douek, Isabelle
Norman, Jane http://orcid.org/0000-0001-6031-6953
Loose, Abi http://orcid.org/0000-0002-9178-102X
Sawyer, Lynn http://orcid.org/0000-0002-7233-4080
Timlin, Laura
Burden, Christy http://orcid.org/0000-0001-6409-5238
-
Funding
Funding for this research was provided by:
NIHR (NIHR203182)
- License Information
-
More Information
Article History
Received: 28 November 2022
Accepted: 7 June 2023
First Online: 11 July 2023
Declarations
:
: UK Health Research Authority (HRA) and ethical approval for the use of human participants has been granted by the South Central Berkshire B Research Ethics Committee (REC; Reference: 22/SC/0246). All participants will be required to give informed, written consent to participate in the study. Where amendments to the protocol or documents are required, relevant approvals will be sought from the HRA. The Chief Investigator will be responsible for decisions to amend the protocol and to determine whether it is substantial or non-substantial, in liaison with the Sponsor (NBT). Amendments to the protocol will be documented using sequential version numbers, with updated documents replaced in the site files.
: Not applicable.
: The authors declare that they have no competing interests.
